Variant ID: 94 |
cDNA Change | c.1061C>T |
---|---|---|
Amino Acid Change | p.Ala354Val (Legacy AA No. 294) | |
Type | Point | |
Effect | Missense | |
Domain | Serine Protease | |
Sequence Context | GCC > GTC | |
Location | Exon( 9) | |
Minor Allele Frequency (MAF) | 0.0007488 |
The details of the cases reported with the above variant is as below
Case ID | Other Variants found in case | Genotype | FVII:C (%) | FVII:Ag (%) | Reported Clinical Severity | Reference | Comments | ||
---|---|---|---|---|---|---|---|---|---|
TF-Unknown | TF-Human | TF-Rabbit | |||||||
10 | 9 | Heterozygous | 14-40 | asymptomatic | Wulff et al 2000 | ||||
25 | 5 | Heterozygous | 18 | 38 | unknown | Bernardi et al 1994b | |||
57 | 7 | Homozygous | 6 | 61 | unknown | Wulff et al 2000 | |||
58 | 3 | Homozygous | <2 | <2 | 2 | moderate | Arbini et al 1994 | ||
59 | 3 | Homozygous | <2 | <2 | 3 | moderate | Arbini et al 1994 | ||
60 | 3 | Homozygous | <2 | <2 | 3 | moderate | Arbini et al 1994 | ||
87 | 8 | Homozygous | <1 | <1 | unknown | Wulff et al 2000 | |||
101 | 5 | Heterozygous | 7 | 25 | unknown | Bernardi et al 1994b | |||
103 | 3 | Homozygous | <2 | <2 | 3 | severe | Arbini et al 1994 | ||
104 | 3 | Homozygous | <2 | <2 | 1 | moderate | Arbini et al 1994 | ||
105 | 3 | Homozygous | <2 | <2 | 1 | moderate | Arbini et al 1994 | ||
108 | 3 | Homozygous | <2 | <2 | 4 | moderate | Arbini et al 1994 | ||
109 | 2 | Heterozygous | 28 | unknown | Herrmann et al 1997 | ||||
110 | 3 | Homozygous | <2 | <2 | 2 | moderate | Arbini et al 1994 | ||
111 | 3 | Heterozygous | 40 | 44 | 45 | asymptomatic | Arbini et al 1994 | ||
112 | 3 | Heterozygous | 52 | 44 | 43 | mild | Arbini et al 1994 | ||
113 | 3 | Heterozygous | 38 | 27 | 34 | asymptomatic | Arbini et al 1994 | ||
114 | 3 | Homozygous | 3 | 4 | 17 | moderate | Arbini et al 1994 | ||
115 | 3 | Heterozygous | 40 | 36 | 42 | asymptomatic | Arbini et al 1994 | ||
116 | 3 | Heterozygous | 60 | 62 | 56 | asymptomatic | Arbini et al 1994 | ||
117 | 3 | Homozygous | 4 | 4 | 12 | moderate | Arbini et al 1994 | ||
118 | 2 | Homozygous | 5 | 11 | 47 | moderate | Arbini et al 1994 | ||
153 | 8 | Heterozygous | 2 | mild | Giansily-Blaizot et al 2001 | Female | |||
155 | 7 | Heterozygous | 4 | 48 | mild | Giansily-Blaizot et al 2001 | |||
168 | 9 | Heterozygous | <1 | 10 | unknown | Wulff et al 2000 | |||
169 | 9 | Heterozygous | 1 | 1 | mild | Wulff et al 2000 | |||
171 | 2 | Heterozygous | 45 | 30 | 50 | asymptomatic | Arbini et al 1994 | ||
213 | 9 | Heterozygous | 08-Dec | unknown | Wulff et al 2000 | ||||
225 | 8 | Heterozygous | <1 | severe | Giansily-Blaizot et al 2001 | ||||
230 | 2 | Heterozygous | 73 | 75 | 82 | asymptomatic | Arbini et al 1994 | ||
245 | 8 | Heterozygous | 4 | unknown | Wulff et al 2000 | ||||
292 | 9 | Heterozygous | 15 | severe | Wulff et al 2000 | ||||
294 | 4 | Heterozygous | 2 | 7 | severe | Millar et al 2000 | |||
328 | 8 | Heterozygous | 9 | 31 | mild | Wulff et al 2000 | |||
379 | 3 | Heterozygous | <1 | <1 | severe | Carew et al 1998 | |||
381 | 4 | Heterozygous | 59 | 98 | unknown | Bernardi et al 1994b | |||
465 | 2 | Heterozygous | 41 | 84 | Marty et al 2008 | thrombotic episode | |||
488 | 2 | Heterozygous | 4 | 30 | Mild | Herrmann et al 2000 | |||
489 | 3 | Heterozygous | 15 | UK | Moderate | Herrmann et al 2000 | |||
490 | 3 | Heterozygous | 1.3 | 0.9 | Mild | Herrmann et al 2000 | |||
493 | 3 | Heterozygous | <1 | UK | Mild | Herrmann et al 2000 | |||
497 | 3 | Heterozygous | 5 | UK | Moderate | Herrmann et al 2000 | |||
499 | 3 | Heterozygous | 10 | UK | Mild | Herrmann et al 2000 | |||
501 | 3 | Heterozygous | 10 | UK | Mild | Herrmann et al 2000 | |||
503 | 1 | Heterozygous | 12 | UK | Asymptomatic | Herrmann et al 2000 | |||
504 | 2 | Heterozygous | 23 | 52 | Asymptomatic | Herrmann et al 2000 | |||
505 | 3 | Heterozygous | <1 | <1 | Mild | Herrmann et al 2000 | |||
530 | 1 | Homozygous | UK | UK | Severe | Herrmann et al 2009 | |||
531 | 1 | Homozygous | UK | UK | Severe | Herrmann et al 2009 | |||
532 | 1 | Homozygous | UK | UK | Asymptomatic | Herrmann et al 2009 | |||
533 | 1 | Homozygous | UK | UK | Asymptomatic | Herrmann et al 2009 | |||
534 | 1 | Homozygous | UK | UK | Asymptomatic | Herrmann et al 2009 | |||
535 | 1 | Homozygous | UK | UK | Asymptomatic | Herrmann et al 2009 | |||
536 | 1 | Homozygous | UK | UK | Moderate | Herrmann et al 2009 | |||
537 | 1 | Homozygous | UK | UK | Moderate | Herrmann et al 2009 | |||
538 | 1 | Homozygous | UK | UK | Moderate | Herrmann et al 2009 | |||
539 | 1 | Homozygous | UK | UK | Moderate | Herrmann et al 2009 | |||
540 | 1 | Homozygous | 31 | UK | Mild | Herrmann et al 2009 | |||
541 | 1 | Homozygous | 3 | 37 | Moderate | Herrmann et al 2009 | |||
542 | 1 | Homozygous | 6 | 48 | Asymptomatic | Herrmann et al 2009 | |||
543 | 1 | Homozygous | 6 | 40 | Mild | Herrmann et al 2009 | |||
544 | 1 | Homozygous | UK | UK | Herrmann et al 2009 | thrombotic episode | |||
545 | 2 | Homozygous | 1 | UK | Mild | Herrmann et al 2009 | |||
546 | 2 | Homozygous | UK | UK | Severe | Herrmann et al 2009 | |||
547 | 2 | Homozygous | UK | UK | Asymptomatic | Herrmann et al 2009 | |||
548 | 2 | Homozygous | UK | UK | Asymptomatic | Herrmann et al 2009 | |||
549 | 2 | Homozygous | UK | UK | Asymptomatic | Herrmann et al 2009 | |||
550 | 2 | Homozygous | UK | UK | Asymptomatic | Herrmann et al 2009 | |||
551 | 2 | Homozygous | 0_<2 | 0_<2 | Severe | Herrmann et al 2009 | |||
552 | 2 | Homozygous | 0_<2 | 0_<2 | Severe | Herrmann et al 2009 | |||
553 | 2 | Homozygous | 0_<2 | 0_<2 | Severe | Herrmann et al 2009 | |||
554 | 2 | Homozygous | 0_<2 | 0_<2 | Herrmann et al 2009 | thrombotic episode | |||
555 | 2 | Homozygous | 0_<2 | 0_<2 | Herrmann et al 2009 | thrombotic episode | |||
556 | 2 | Homozygous | 0_<2 | 0_<2 | Herrmann et al 2009 | thrombotic episode | |||
557 | 2 | Homozygous | 0_<2 | 0_<2 | Moderate | Herrmann et al 2009 | |||
558 | 2 | Homozygous | 0_<2 | 0_<2 | Moderate | Herrmann et al 2009 | |||
559 | 2 | Homozygous | 0_<2 | 0_<2 | Moderate | Herrmann et al 2009 | |||
560 | 2 | Homozygous | 0_<2 | 0_<2 | Moderate | Herrmann et al 2009 | |||
561 | 2 | Homozygous | 0_<2 | 0_<2 | Moderate | Herrmann et al 2009 | |||
566 | 2 | Heterozygous | 4 | UK | Severe | Herrmann et al 2009 | |||
567 | 3 | Heterozygous | 1 | UK | Severe | Herrmann et al 2009 | |||
568 | 3 | Heterozygous | <1 | UK | Severe | Herrmann et al 2009 | |||
571 | 2 | Heterozygous | 9 | UK | Severe | Herrmann et al 2009 | |||
572 | 3 | Heterozygous | 1 | UK | Severe | Herrmann et al 2009 | |||
573 | 3 | Heterozygous | 3 | UK | Severe | Herrmann et al 2009 | |||
575 | 3 | Heterozygous | 8 | UK | Severe | Herrmann et al 2009 | |||
578 | 3 | Heterozygous | 2 | UK | Severe | Herrmann et al 2009 | |||
581 | 3 | Heterozygous | 17 | UK | Severe | Herrmann et al 2009 | |||
582 | 2 | Heterozygous | <1 | UK | Severe | Herrmann et al 2009 | |||
717 | 2 | Homozygous | <1 | 1 | Moderate | Fromovich-Amit et al 2004 | |||
742 | 2 | Heterozygous | 9 | 38 | Moderate | Mariani et al 2003 | |||
743 | 1 | Heterozygous | 3 | 47 | Mariani et al 2003 | thrombotic episode | |||
745 | 2 | Heterozygous | 3 | 58 | Mariani et al 2003 | Haemorrhages and Thrombosis | |||
746 | 2 | Homozygous | 1.2 | 2.6 | Mariani et al 2003 | Haemorrhages and Thrombosis | |||
747 | 2 | Homozygous | 0.8 | 2 | Mariani et al 2003 | Haemorrhages and Thrombosis | |||
748 | 2 | Heterozygous | 5 | 29 | Mariani et al 2003 | Haemorrhages and Thrombosis | |||
749 | 1 | Homozygous | 6 | 40 | Mariani et al 2003 | thrombotic episode | |||
784 | 2 | Heterozygous | 8% | 24% | moderate | Kavlie et al 2003 | |||
812 | 1 | Heterozygous | 42 | 42 | UK | Mild | Cutler et al 2005 |